Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in chronic hepatitis B patients

Biomedical Journal

Volumn 38, Issue 3, 2015, Pages 250-256

  Liao, Chen Chih ^a   Hsu, Chao Wei ^a   Gu, Po Wen ^a   Yeh, Chau Ting ^a   Lin, Shi Ming ^a   Chiu, Cheng Tang ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

hepatitis B; quantification of hepatitis B surface antigen; treatment na ve chronic hepatitis B

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOTINYLATION; CHEMOLUMINESCENCE; CHRONIC HEPATITIS B; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; IMMUNOLOGICAL TOLERANCE; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; BLOOD; COMPARATIVE STUDY; HEPATITIS B VIRUS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; TAIWAN; YOUNG ADULT;

ADULT; AGED; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; TAIWAN; YOUNG ADULT;

EID: 84933529230     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.4103/2319-4170.143485     Document Type: Article

References (22)

1. Maynard JE. Hepatitis B: Global importance and need for control. Vaccine 1990;8 Suppl:S18-20.
2. Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990;263:1218-22.
3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107.
4. Wursthorn K, Jaroszewicz J, Zacher BJ, Darnedde M, Raupach R, Mederacke I, et al. Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum. J Clin Virol 2011;50:292-6.
5. Sonneveld MJ, Rijckborst V, Boucher CA, Zwang L, Beersma MF, Hansen BE, et al. A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B. J Clin Virol 2011;51:175-8.
6. Tseng TC, Kao JH. Clinical utility of quantitative HBsAg in natural history and nucleos (t) ide analogue treatment of chronic hepatitis B: New trick of old dog. J Gastroenterol 2013;48:13-21.
7. Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, Brunetto MR, et al. Hepatitis B surface antigen quantification: Why and how to use it in 2011-a core group report. J Hepatol 2011;55:1121-31.
8. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective. J Hepatol 2010;52:514-22.
9. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia. J Hepatol 2010;52:508-13.
10. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582-92.
11. Bonino F, Ofenloch B, Melchior W, Upmeier B, Rossler D, van der Helm W. Quantitative Assessment of Serum Hbsag Level Using the Elecsys (R) Hbsag Ii Screening Assay: Results of a Feasibility Study. Hepatology 2008;48:726a.
12. Deguchi M, Yamashita N, Kagita M, Asari S, Iwatani Y, Tsuchida T, et al. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 2004;115:217-22.
13. Sonneveld MJ, Zoutendijk R, Janssen HL. Hepatitis B surface antigen monitoring and management of chronic hepatitis B. J Viral Hepat 2011;18:449-57.
14. Liaw YF. Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review. Hepatology 2011;53:2121-9.
15. Muhlbacher A, Weber B, Burgisser P, Eiras A, Cabrera J, Louisirirotchanakul S, et al. Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants. Med Microbiol Immunol 2008;197:55-64.
16. Louisirirotchanakul S, Khupulsup K, Akraekthalin S, Chan KP, Saw S, Aw TC, et al. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays. J Med Virol 2010;82:755-62.
17. Jia JD, Hong M, Wei L, Zhang XX, Mao YL, Wang LL, et al. Multicentre evaluation of the Elecsys hepatitis B surface antigen II assay for detection of HBsAg in comparison with other commercially available assays. Med Microbiol Immunol 2009;198:263-9.
18. Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, Yurdaydin C, et al. Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 2009;49:1141-50.
19. Marcellin P, Brunetto M, Bonino F, Hadziyannis SJ, Kapprell HP, McCloud PI, et al. In Patients with Hbeag-Negative Chronic Hepatitis B Hbsag Serum Levels Early during Treatment with Peginterferon Alfa-2a Predict Hbsag Clearance 4 Years Post-Treatment. Hepatology 2008;48:718-9a.
20. Moucari R, Korevaar A, Lada O, Martinot-Peignoux M, Boyer N, Mackiewicz V, et al. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study. J Hepatol 2009;50:1084-92.
21. Lok AS, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology 2009;50:661-2.
22. European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B. J Hepatol 2009;50:227-42.